I typically combine it with TB-500 because they support different aspects of the healing process
Peptide clears from blood BUT cellular processes continue Duration of cellular effects: Why this matters: Don't need continuous high levels in blood Single injection triggers multi-day effects 2-3x weekly dosing sufficient (not daily required) Cellular "memory" of GHK-Cu exposure Cumulative effects with repeated dosing: Each dose builds on previous Collagen accumulation over weeks Tissue remodeling compounds Results improve with consistent use Comparing GHK-Cu to other peptides Half-life comparison table: GHK-Cu positioning: Short half-life like Ipamorelin But longer cellular effects than half-life suggests Middle-ground dosing frequency (not daily, not weekly) Cumulative benefits with consistency See our BPC-157 guide , TB-500 guide , peptide dosing guide , and peptide dosage chart

Key Peptides That Support Prolotherapy It is recommended to use a combination of injectable peptides to enhance the benefits of prolotherapy, including: GLOW (BPC-157 + TB-500 + GHK-Cu) GLOW is a proprietary blend of three synergistic peptides designed to promote comprehensive tissue regeneration: BPC-157 (5mg) : Enhances tendon and ligament healing, reduces inflammation, improves angiogenesis TB-500 (10mg) : Supports cell migration, modulates inflammation, prevents scar tissue GHK-Cu (27mg) : Stimulates collagen and elastin, improves skin and soft tissue repair GLOW is ideal in the early healing phase post-prolotherapy to amplify fibroblast activity and new capillary formation , both crucial for regenerative success
Welss, T., Basketter, D
As shown in Figure 3C,D, the expression of SYP protein in the APP/PS1 group was lower than that in the WT group
Glutathione plays a critical role in strengthening these defenses